The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Thioredoxin signaling as a target for cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1
Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., & Ichijo, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2596 · Cited by 2,377
The thioredoxin system in cancer
Arnér, E. S. J., & Holmgren, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.10.009 · Cited by 589
Thioredoxin Reductase Is Irreversibly Modified by Curcumin
Fang, J., Lu, J., & Holmgren, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414645200 · Cited by 521
Ungerstedt, J. S., Sowa, Y., Xu, W.-S., Shao, Y., Dokmanovic, M., Perez, G., Ngo, L., Holmgren, A., Jiang, X., & Marks, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408732102 · Cited by 503
Mehta, M. P., Rodrigus, P., Terhaard, C. H. J., Rao, A., Suh, J., Roa, W., Souhami, L., Bezjak, A., Leibenhaut, M., Komaki, R., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.122 · Cited by 463
(2002) · PubMed · Cited by 349
The PERK/eIF2α/ATF4 module of the UPR in hypoxia resistance and tumor growth
Fels, D. R., & Koumenis, C. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.7.2967 · Cited by 346
Sandalova, T., Zhong, L., Lindqvist, Y., Holmgren, A., & Schneider, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171178698 · Cited by 343
The thioredoxin-thioredoxin reductase system: over-expression in human cancer.
Lincoln, D. T., Emadi, E. M. A., Tonissen, K. F., & Clarke, F. M. (2003) · PubMed · Cited by 337
On the potential of thioredoxin reductase inhibitors for cancer therapy
Urig, S., & Becker, K. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.09.004 · Cited by 337
Lu, J., Papp, L. V., Fang, J., Rodriguez-Nieto, S., Zhivotovsky, B., & Holmgren, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3310 · Cited by 326
Yoo, M.-H., Xu, X.-M., Carlson, B. A., Gladyshev, V. N., & Hatfield, D. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600012200 · Cited by 270
(2003) · PubMed · Cited by 250
Mustacich, D. J., & Powis, G. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460001 · Cited by 231
Self-citationRaffel, J., Bhattacharyya, A. K., Gallegos, A., Cui, H., Einspahr, J. G., Alberts, D. S., & Powis, G. (2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(03)00068-4 · Cited by 219
Self-citationGold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions
Pia Rigobello, M., Messori, L., Marcon, G., Agostina Cinellu, M., Bragadin, M., Folda, A., Scutari, G., & Bindoli, A. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.04.020 · Cited by 213
Cunnea, P. M., Miranda-Vizuete, A., Bertoli, G., Simmen, T., Damdimopoulos, A. E., Hermann, S., Leinonen, S., Huikko, M. P., Gustafsson, J.-Å., Sitia, R., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206995200 · Cited by 201
Meuillet, E. J., Mahadevan, D., Berggren, M., Coon, A., & Powis, G. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.04.020 · Cited by 192
Self-citationGrogan, T. M., Fenoglio-Prieser, C., Zeheb, R., Bellamy, W., Frutiger, Y., Vela, E., Stemmerman, G., Macdonald, J., Richter, L., Gallegos, A., et al. (2000) · Human Pathology · doi:10.1053/hp.2000.6546 · Cited by 188
Self-citationKakolyris, S., Giatromanolaki, A. N., Koukourakis, M. I., Powis, G., Souglakos, J., Sivridis, E., Georgoulias, V., Gatter, K. C., & Harris, A. L. (2001) · PubMed · Cited by 185
Self-citationHigh Thioredoxin Expression Is Associated with Resistance to Docetaxel in Primary Breast Cancer
Kim, S. J., Miyoshi, Y., Taguchi, T., Tamaki, Y., Nakamura, H., Yodoi, J., Kato, K., & Noguchi, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0449 · Cited by 185
Expression of thioredoxin and glutaredoxin, redox-regulating proteins, in pancreatic cancer.
Nakamura, H., Bai, J., Nishinaka, Y., Ueda, S., Sasada, T., Ohshio, G., Imamura, M., Takabayashi, A., Yamaoka, Y., & Yodoi, J. (2000) · PubMed · Cited by 176
Similarities and differences in the thioredoxin superfamily
Carvalho, A. T. P., Fernandes, P. A., & Ramos, M. J. (2005) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2005.06.012 · Cited by 165
Motexafin gadolinium: A novel redox active drug for cancer therapy
Magda, D., & Miller, R. A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.09.002 · Cited by 162
Gallegos, A. C., Gasdaska, J. R., Taylor, C. W., Paine-Murrieta, G. D., Goodman, D., Gasdaska, P. Y., Berggren, M. I., Briehl, M. M., & Powis, G. (1996) · PubMed · Cited by 161
Self-citationKirkpatrick, D. L., Kuperus, M., Dowdeswell, M., Potier, N., Donald, L. J., Kunkel, M. W., Berggren, M. I., Angulo, M., & Powis, G. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00597-2 · Cited by 138
Self-citationIdentification of a Novel Thioredoxin-related Transmembrane Protein
Matsuo, Y., Akiyama, N., Nakamura, H., Yodoi, J., Noda, M., & Kizaka‐Kondoh, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011037200 · Cited by 112
Cassidy, P. B., Edes, K., Nelson, C. C., Parsawar, K., Fitzpatrick, F. A., & Moos, P. J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl111 · Cited by 106
Kawahara, N., Tanaka, T., Yokomizo, A., Nanri, H., Ono, M., Wada, M., Kohno, K., Takenaka, K., Sugimachi, K., & Kuwano, M. (1996) · PubMed · Cited by 105
Ramanathan, R. K., Kirkpatrick, D. L., Belani, C. P., Friedland, D., Green, S. B., Chow, H. ‐. S., Cordova, C. A., Stratton, S. P., Sharlow, E. R., Baker, A. F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2250 · Cited by 104
Self-citationCsiki, I., Yanagisawa, K., Haruki, N., Nadaf, S., Morrow, J. D., Johnson, D. H., & Carbone, D. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1357 · Cited by 96
EIevated serum level of Thioredoxin in patients with Hepatocellular Carcinoma
Miyazaki, K., Noda, N., Okada, S., Hagiwara, Y., Miyata, M., Sakurabayashi, I., Yamaguchi, N., Sügimura, T., Terada, M., & Wakasugi, H. (1998) · Biotherapy · doi:10.1023/a:1008032703468 · Cited by 93
Baker, A. F., Dragovich, T., Tate, W. R., Ramanathan, R. K., Roe, D., Hsu, C.-H., Kirkpatrick, D. L., & Powis, G. (2006) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.09.001 · Cited by 90
Self-citationElucidation of Thioredoxin as a Molecular Target for Antitumor Quinols
Bradshaw, T. D., Matthews, C. S., Cookson, J. C., Chew, E., Shah, M. A., Bailey, K., Monks, A. P., Harris, E. D., Westwell, A. D., Wells, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4141 · Cited by 85
Expression of Antioxidant Enzymes in Astrocytic Brain Tumors
Haapasalo, H. K., Kyläniemi, M., Paunu, N., Kinnula, V. L., & Soini, Y. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00015.x · Cited by 69
Chung, J. W., Jeon, J.-H., Suk‐Ran, Y. O. O. N., & Choi, I. (2006) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2006.00156.x · Cited by 68
Powis, G., Wipf, P., Lynch, S. M., Birmingham, A., & Kirkpatrick, D. L. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0487 · Cited by 67
Self-citationArnold, N. B., Ketterer, K., Kleeff, J. H., Friess, H., Büchler, M. W., & Korc, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2999 · Cited by 64
Mukherjee, A., Westwell, A. D., Bradshaw, T. D., Stevens, M. F. G., Carmichael, J., & Martin, S. G. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602338 · Cited by 56
Engman, L., Al‐Maharik, N., McNaughton, M., et al. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.08.021 · Cited by 53
Jones, D. T., Pugh, C. W., Wigfield, S., Stevens, M. F. G., & Harris, A. L. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2380 · Cited by 48
The nonclassic secretion of thioredoxin is not sensitive to redox state
Tanudji, M., Hevi, S., & Chuck, S. L. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00521.2002 · Cited by 43
Kim, W. S., Cho, H., Lee, S., Kim, Y.-J., & Kim, K. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.4.1049 · Cited by 26
Kirkpatrick, D. L., Watson, S., Kunkel, M. W., Fletcher, S., Ulhaq, S., & Powis, G. (1999) · PubMed · Cited by 19
Self-citationOsborne, S. A., Hawkes, H.-J. K., Baldwin, B. L., Alexander, K. A., Svingen, T., Clarke, F. M., & Tonissen, K. F. (2006) · Biochemical Journal · doi:10.1042/bj20060076 · Cited by 17
Kasperczyk, H., Ferla-Brühl, K. L., Westhoff, A., Debatin, K., & Fulda, S. (2005) · Cancer Research · Cited by 6
Cited by
Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837
On the medicinal chemistry of gold complexes as anticancer drugs
Ott, I. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.019 · Cited by 825
Hanschmann, E.-M., Godoy, J. R., Berndt, C., Hudemann, C., & Lillig, C. H. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4599 · Cited by 677
Oxidative Stress in Cancer Cell Metabolism
Arfin, S., Jha, N. K., Jha, S. K., Kesari, K. K., Ruokolainen, J., Roychoudhury, S., Rathi, B., & Kumar, D. (2021) · Antioxidants · doi:10.3390/antiox10050642 · Cited by 665
Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy
Ushio-Fukai, M., & Nakamura, Y. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.044 · Cited by 651
Metadata
- Authors
- Powis, G., & Kirkpatrick, D. L.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 7
- Issue
- 4
- Pages
- 392-397
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W2090162098
- Cited by
- 264
- References
- 46
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.